GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Greenfern Industries Ltd (NZSE:GFI) » Definitions » 5-Year EBITDA Growth Rate

Greenfern Industries (NZSE:GFI) 5-Year EBITDA Growth Rate : 0.00% (As of Mar. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Greenfern Industries 5-Year EBITDA Growth Rate?

Greenfern Industries's EBITDA per Share for the six months ended in Mar. 2023 was NZ$-0.02.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Competitive Comparison of Greenfern Industries's 5-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Greenfern Industries's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Greenfern Industries's 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Greenfern Industries's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Greenfern Industries's 5-Year EBITDA Growth Rate falls into.



Greenfern Industries 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Greenfern Industries  (NZSE:GFI) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Greenfern Industries 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Greenfern Industries's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Greenfern Industries (NZSE:GFI) Business Description

Traded in Other Exchanges
N/A
Address
115 Queen Street, Level 8, General Capital House, Auckland, NTL, NZL, 1040
Greenfern Industries Ltd is committed to the environmentally friendly production of medicinal cannabis and hemp-based products. It operates in two segments, Cannabis and therapeutics products the operations of this segment reflect the activities of manufacture and distribution of cannabis products, Electricity generation this segment includes the generation and distribution of electricity. The hemp seed and its by-products are used for a range of different products from a high protein ingredient in a plant-based meat substitute, a hemp-based skincare range, and hemp-based beverages amongst other things.

Greenfern Industries (NZSE:GFI) Headlines

From GuruFocus

Top 5 1st Quarter Trades of Donald Smith & Co

By GuruFocus Research GuruFocus Editor 05-10-2022

Top 5 2nd Quarter Trades of CoreCommodity Management, LLC

By GuruFocus Research GuruFocus Editor 08-15-2022

Top 5 1st Quarter Trades of Donald Smith & Co

By GuruFocus Research GuruFocus Editor 05-09-2022

Gold Fields Announces 2030 ESG Targets

By PRNewswire PRNewswire 12-01-2021

GOLD FIELDS PROVIDES UPDATE ON PROPOSED YAMANA GOLD ACQUISITION

By PRNewswire PRNewswire 10-21-2022